17-(3,4-Dimethoxyphenethyl)-3-methoxymorphinan

Suppliers

Names

[ CAS No. ]:
63690-30-2

[ Name ]:
17-(3,4-Dimethoxyphenethyl)-3-methoxymorphinan

[Synonym ]:
(-)-17-(3,4-Dimethoxyphenethyl)-3-methoxymorphinan
Morphinan,17-(3,4-dimethoxyphenethyl)-3-methoxy-,(-)

Chemical & Physical Properties

[ Density]:
1.16g/cm3

[ Boiling Point ]:
552ºC at 760 mmHg

[ Molecular Formula ]:
C27H35NO3

[ Molecular Weight ]:
421.57200

[ Flash Point ]:
149.8ºC

[ Exact Mass ]:
421.26200

[ PSA ]:
30.93000

[ LogP ]:
4.95140

[ Index of Refraction ]:
1.599

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QC7695000
CHEMICAL NAME :
Morphinan, 17-(3,4-dimethoxyphenethyl)-3-methoxy-, (-)-
CAS REGISTRY NUMBER :
63690-30-2
BEILSTEIN REFERENCE NO. :
0057617
LAST UPDATED :
199712
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C27-H35-N-O3
MOLECULAR WEIGHT :
421.63
WISWESSER LINE NOTATION :
T6 G666/FQ 2AF Q FX ONT&TTJ IO1 O2R CO1 DO1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
31ZPAG "Synthetic Analgesics," Oxford, Pergamon Press, 1966 Volume(issue)/page/year: 2,87,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
26 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
31ZPAG "Synthetic Analgesics," Oxford, Pergamon Press, 1966 Volume(issue)/page/year: 2,87,1966

Synthetic Route

Click to get detail synthetic route

Related Compounds

  • 2-(3,4-dimethoxyphenethyl)-3-hydroxyisoindolin-1-one
  • N-(3,4-dimethoxyphenethyl)-3,4-methylenedioxybenzamide
  • N-(3,4-dimethoxyphenethyl)-3,4-dimethoxycyclobutene-1-carboxamide
  • N-(3,4-dimethoxyphenethyl)-3,5-dinitrobenzamide
  • 4-(3,4-Dimethoxyphenethyl)-3,4,5,6-tetrahydro-2,6-methano-2H-1,4-benzoxazocine
  • 1-(3,4-dimethoxyphenethyl)-3-ethyl-5-(phenylsulfinyl)piperidine-2,6-dione
  • 2-(6-chloro-1H-indol-1-yl)-N-(2-hydroxy-2-phenylethyl)acetamide
  • 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-(4-hydroxyphenyl)-5-oxopyrrolidine-3-carboxamide
  • 1-(furan-2-ylmethyl)-5-oxo-N-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carboxamide
  • 2-(2-methoxyethyl)-1,3-dioxo-N-[(2E)-5-(tetrahydrofuran-2-yl)-1,3,4-thiadiazol-2(3H)-ylidene]-2,3-dihydro-1H-isoindole-5-carboxamide
  • N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(2-methoxybenzyl)-5-oxopyrrolidine-3-carboxamide
  • N-{4-[3-(6-fluoro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)-2,5-dioxopyrrolidin-1-yl]phenyl}acetamide
  • 1-(2,4-dimethoxyphenyl)-N-(3-hydroxyphenyl)-5-oxopyrrolidine-3-carboxamide
  • N-(2-hydroxy-2-phenylethyl)-4-(1H-pyrrol-1-yl)benzamide
  • N-[(2E)-5-ethyl-1,3,4-thiadiazol-2(3H)-ylidene]-5-oxo-1-[3-(trifluoromethyl)phenyl]pyrrolidine-3-carboxamide
  • N-(3,5-dichlorophenyl)-1-([1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidine-3-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.